1. Home
  2. KMT vs FTRE Comparison

KMT vs FTRE Comparison

Compare KMT & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMT
  • FTRE
  • Stock Information
  • Founded
  • KMT 1938
  • FTRE 1996
  • Country
  • KMT United States
  • FTRE United States
  • Employees
  • KMT N/A
  • FTRE N/A
  • Industry
  • KMT Industrial Machinery/Components
  • FTRE Medical Specialities
  • Sector
  • KMT Industrials
  • FTRE Health Care
  • Exchange
  • KMT Nasdaq
  • FTRE Nasdaq
  • Market Cap
  • KMT 1.9B
  • FTRE 1.9B
  • IPO Year
  • KMT N/A
  • FTRE N/A
  • Fundamental
  • Price
  • KMT $24.28
  • FTRE $17.69
  • Analyst Decision
  • KMT Hold
  • FTRE Hold
  • Analyst Count
  • KMT 6
  • FTRE 11
  • Target Price
  • KMT $27.67
  • FTRE $23.30
  • AVG Volume (30 Days)
  • KMT 993.2K
  • FTRE 944.5K
  • Earning Date
  • KMT 02-05-2025
  • FTRE 03-10-2025
  • Dividend Yield
  • KMT 3.30%
  • FTRE N/A
  • EPS Growth
  • KMT N/A
  • FTRE N/A
  • EPS
  • KMT 1.28
  • FTRE N/A
  • Revenue
  • KMT $2,036,371,000.00
  • FTRE $2,975,600,000.00
  • Revenue This Year
  • KMT $0.25
  • FTRE N/A
  • Revenue Next Year
  • KMT $2.49
  • FTRE $1.09
  • P/E Ratio
  • KMT $18.94
  • FTRE N/A
  • Revenue Growth
  • KMT N/A
  • FTRE 2.80
  • 52 Week Low
  • KMT $22.50
  • FTRE $16.53
  • 52 Week High
  • KMT $32.18
  • FTRE $41.02
  • Technical
  • Relative Strength Index (RSI)
  • KMT 41.24
  • FTRE 39.63
  • Support Level
  • KMT $23.69
  • FTRE $16.94
  • Resistance Level
  • KMT $24.65
  • FTRE $18.52
  • Average True Range (ATR)
  • KMT 0.58
  • FTRE 0.98
  • MACD
  • KMT 0.14
  • FTRE -0.10
  • Stochastic Oscillator
  • KMT 65.60
  • FTRE 22.59

About KMT Kennametal Inc.

Kennametal Inc is a manufacturer of metalworking tools and wear-resistant engineered components and coatings. The company operates in two business segments; Metal Cutting and Infrastructure. It generates maximum revenue from the Metal Cutting segment. The Metal Cutting segment develops and manufactures high-performance tooling and metal cutting products and services and offers an assortment of standard and custom metal cutting solutions to diverse end markets, including aerospace, general engineering, energy, and transportation. Geographically, it derives maximum revenue from the United States and the rest from Germany, China, Canada, India, Italy, and other countries.

About FTRE Fortrea Holdings Inc.

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: